Cargando…

Isolation and characteristics of CD133(−)/A2B5(+) and CD133(−)/A2B5(−) cells from the SHG139s cell line

In glioma tissues, there are small cell populations with the capability of sustaining tumor formation. These cells are referred to as glioma stem cells (GSCs). However, the presence of subpopulations of GSCs, and the differences between each subpopulation remain to be fully elucidated. In the presen...

Descripción completa

Detalles Bibliográficos
Autores principales:	HAN, YONG, WANG, HANGZHOU, HUANG, YULUN, CHENG, ZHE, SUN, TING, CHEN, GUILIN, XIE, XUESHUN, ZHOU, YOUXIN, DU, ZIWEI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758283/ https://www.ncbi.nlm.nih.gov/pubmed/26498168 http://dx.doi.org/10.3892/mmr.2015.4446

Ejemplares similares

Aggressive invasion is observed in CD133(−)/A2B5(+) glioma-initiating cells
por: SUN, TING, et al.
Publicado: (2015)

miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133- subgroup of human glioma stem cells
por: Wu, Zhiwu, et al.
Publicado: (2022)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

MiR-139-5p reverses CD44(+)/CD133(+)-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells
por: Xu, Ke, et al.
Publicado: (2016)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Elevated expression of Dickkopf-1 increases the sensitivity of human glioma cell line SHG(44 )to BCNU
por: Zhou, Youxin, et al.
Publicado: (2010)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Biological characteristics of a new human glioma cell line transformed into A2B5(+) stem cells
por: Li, Yanyan, et al.
Publicado: (2015)

THE CD133-POSITIVE COLON CANCER CELL PHENOTYPE IS MORE INTERACTIVE WITH THE TUMOR MICROENVIRONMENT COMPARED TO CD133-NEGATIVE CELL
por: Chao, Celia, et al.
Publicado: (2011)

DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies
por: Cervantes-Madrid, Diana, et al.
Publicado: (2017)

Prospectively Isolated Cancer-Associated CD10(+) Fibroblasts Have Stronger Interactions with CD133(+) Colon Cancer Cells than with CD133(−) Cancer Cells
por: Cui, Lin, et al.
Publicado: (2010)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

CD133: a stem cell biomarker and beyond
por: Li, Zhong
Publicado: (2013)

Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma
por: ZHUANG, HUI-WEN, et al.
Publicado: (2013)

Prostate Cancer Stem Cells: The Role of CD133
por: Yang, Jianhui, et al.
Publicado: (2022)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)

Characterization of a new human astrocytoma cell line SHG140: cell proliferation, cell phenotype, karyotype, STR markers and tumorigenicity analysis
por: Li, Yanyan, et al.
Publicado: (2021)

Detection of CD133 (prominin-1) in a human hepatoblastoma cell line (HuH-6 clone 5)
por: Akita, Masumi, et al.
Publicado: (2013)

Increased CD133(+) cell infiltration in the rat brain following fluid percussion injury☆
por: Wei, Ming, et al.
Publicado: (2012)

Prognostic significance of CD133 and ABCB5 expression in papillary thyroid carcinoma
por: Karas Zella, Maria Augusta, et al.
Publicado: (2020)

CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
por: Barrantes-Freer, Alonso, et al.
Publicado: (2015)

Systemic Infusion of Expanded CD133(+) Cells and Expanded CD133(+) Cell-Derived EVs for the Treatment of Ischemic Cardiomyopathy in a Rat Model of AMI
por: Angulski, Addeli B. B., et al.
Publicado: (2019)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

Proteasomes Are Critical for Maintenance of CD133+CD24+ Kidney Progenitor Cells
por: Al-Marsoummi, Sarmad, et al.
Publicado: (2023)

Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines
por: Veselska, Renata, et al.
Publicado: (2008)

Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines
por: NUNUKOVA, ALENA, et al.
Publicado: (2015)

miR-200b inhibits CD133(+) glioma cells by targeting the AKT pathway
por: Liu, Aiqun, et al.
Publicado: (2017)

Prognostic Value of CD133 and SOX2 in Advanced Cancer
por: Han, Susu, et al.
Publicado: (2019)

The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251
por: Zhou, Youxin, et al.
Publicado: (2011)

Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications
por: Kelly, Sarah E., et al.
Publicado: (2010)

CD133 expression in chemo-resistant Ewing sarcoma cells
por: Jiang, Xiaohua, et al.
Publicado: (2010)

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
por: Rountree, C. Bart, et al.
Publicado: (2011)

Significance of CD133 expression in esophageal squamous cell carcinoma
por: Okamoto, Hiroshi, et al.
Publicado: (2013)

Expression of CD133 in endometrial cancer cells and its implications
por: Ding, Dah-Ching, et al.
Publicado: (2017)

CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009)

CD133, Selectively Targeting the Root of Cancer
por: Schmohl, Jörg U., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gj1clhlhqifqpri0v474v6djle